http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111718352-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate | 2020-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111718352-B |
| titleOfInvention | Compound and pharmaceutically acceptable salt thereof |
| abstract | The invention discloses a compound or a pharmaceutically acceptable salt thereof, wherein the compound comprises a part derived from temozolomide and a part derived from elemene, and the part derived from temozolomide and the part derived from elemene are directly covalently connected or are covalently connected through a linker. Also disclosed are compositions comprising the above compounds, and methods of treating cancer. |
| priorityDate | 2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.